163 related articles for article (PubMed ID: 37061730)
1. Mitochondrial creatine kinase 1 regulates the cell cycle in non-small cell lung cancer via activation of cyclin-dependent kinase 4.
Yang M; Wang X; Ye Z; Liu T; Meng Y; Duan Y; Yuan X; Yue X; Deng W; Liu RY
Respir Res; 2023 Apr; 24(1):111. PubMed ID: 37061730
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial creatine kinase 1 in non-small cell lung cancer progression and hypoxia adaptation.
Li M; Liu H; Li J; Guo S; Lv Y
Respir Res; 2021 Jul; 22(1):190. PubMed ID: 34210337
[TBL] [Abstract][Full Text] [Related]
3. miR-31/QKI-5 axis facilitates cell cycle progression of non-small-cell lung cancer cells by interacting and regulating p21 and CDK4/6 expressions.
Zhu W; Yu Y; Fang K; Xiao S; Ni L; Yin C; Huang X; Wang X; Zhang Y; Le HB; Cui R
Cancer Med; 2023 Feb; 12(4):4590-4604. PubMed ID: 36172919
[TBL] [Abstract][Full Text] [Related]
4. MiR-613 induces cell cycle arrest by targeting CDK4 in non-small cell lung cancer.
Li D; Li DQ; Liu D; Tang XJ
Cell Oncol (Dordr); 2016 Apr; 39(2):139-47. PubMed ID: 26744345
[TBL] [Abstract][Full Text] [Related]
5. Highly expressed long non-coding RNA CRNDE promotes cell proliferation through PI3K/AKT signalling in non-small cell lung carcinoma.
Liu XX; Xiong HP; Huang JS; Qi K; Xu JJ
Clin Exp Pharmacol Physiol; 2017 Aug; 44(8):895-902. PubMed ID: 28477368
[TBL] [Abstract][Full Text] [Related]
6. Lower miR-340 expression predicts poor prognosis of non-small cell lung cancer and promotes cell proliferation by targeting CDK4.
Qin Y; Zhou X; Huang C; Li L; Liu H; Liang N; Chen Y; Ma D; Han Z; Xu X; He J; Li S
Gene; 2018 Oct; 675():278-284. PubMed ID: 29935356
[TBL] [Abstract][Full Text] [Related]
7. Linc00703 suppresses non-small cell lung cancer progression by modulating CyclinD1/CDK4 expression.
Sun HB; Han XL; Zhong M; Yu DJ
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):6131-6138. PubMed ID: 32572878
[TBL] [Abstract][Full Text] [Related]
8. MiR-34b-3p represses cell proliferation, cell cycle progression and cell apoptosis in non-small-cell lung cancer (NSCLC) by targeting CDK4.
Feng H; Ge F; Du L; Zhang Z; Liu D
J Cell Mol Med; 2019 Aug; 23(8):5282-5291. PubMed ID: 31199581
[TBL] [Abstract][Full Text] [Related]
9. Acetyl-11-keto-β-boswellic acid enhances the cisplatin sensitivity of non-small cell lung cancer cells through cell cycle arrest, apoptosis induction, and autophagy suppression via p21-dependent signaling pathway.
Lv M; Zhuang X; Zhang Q; Cheng Y; Wu D; Wang X; Qiao T
Cell Biol Toxicol; 2021 Apr; 37(2):209-228. PubMed ID: 32562082
[TBL] [Abstract][Full Text] [Related]
10. Sirtuin 7 promotes non‑small cell lung cancer progression by facilitating G1/S phase and epithelial‑mesenchymal transition and activating AKT and ERK1/2 signaling.
Zhao Y; Ye X; Chen R; Gao Q; Zhao D; Ling C; Qian Y; Xu C; Tao M; Xie Y
Oncol Rep; 2020 Sep; 44(3):959-972. PubMed ID: 32705247
[TBL] [Abstract][Full Text] [Related]
11. [Effect of ubiquitous mitochondrial creatine kinase on cisplatin sensitivity of human nasopharyngeal carcinoma cell line CNE-1].
Lan RL; Huang F; Chen RQ; Wang Z; Chen JY; Lin JA; Fu LX
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Jul; 53(7):524-529. PubMed ID: 30032496
[No Abstract] [Full Text] [Related]
12. piR-651 promotes tumor formation in non-small cell lung carcinoma through the upregulation of cyclin D1 and CDK4.
Li D; Luo Y; Gao Y; Yang Y; Wang Y; Xu Y; Tan S; Zhang Y; Duan J; Yang Y
Int J Mol Med; 2016 Sep; 38(3):927-36. PubMed ID: 27431575
[TBL] [Abstract][Full Text] [Related]
13. Aldolase A promotes proliferation and G
Fu H; Gao H; Qi X; Zhao L; Wu D; Bai Y; Li H; Liu X; Hu J; Shao S
Cancer Commun (Lond); 2018 May; 38(1):18. PubMed ID: 29764507
[TBL] [Abstract][Full Text] [Related]
14. Induction of G2/M Cell Cycle Arrest via p38/p21
Pai JT; Hsu MW; Leu YL; Chang KT; Weng MS
Molecules; 2021 Aug; 26(17):. PubMed ID: 34500594
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of tripartite motif containing 26 inhibits non-small cell lung cancer cell growth by suppressing PI3K/AKT signaling.
Tao JL; Luo M; Sun H; Zhao HM; Sun QS; Huang ZM
Kaohsiung J Med Sci; 2020 Jun; 36(6):417-422. PubMed ID: 32052576
[TBL] [Abstract][Full Text] [Related]
16. Direct repression of the oncogene CDK4 by the tumor suppressor miR-486-5p in non-small cell lung cancer.
Shao Y; Shen YQ; Li YL; Liang C; Zhang BJ; Lu SD; He YY; Wang P; Sun QL; Jin YX; Ma ZL
Oncotarget; 2016 Jun; 7(23):34011-21. PubMed ID: 27049724
[TBL] [Abstract][Full Text] [Related]
17. Orai3 constitutes a native store-operated calcium entry that regulates non small cell lung adenocarcinoma cell proliferation.
Ay AS; Benzerdjeb N; Sevestre H; Ahidouch A; Ouadid-Ahidouch H
PLoS One; 2013; 8(9):e72889. PubMed ID: 24058448
[TBL] [Abstract][Full Text] [Related]
18. Oncoprotein HBXIP promotes tumorigenesis through MAPK/ERK pathway activation in non-small cell lung cancer.
Zhang J; Sun B; Ruan X; Hou X; Zhi J; Meng X; Zheng X; Gao M
Cancer Biol Med; 2021 Feb; 18(1):105-119. PubMed ID: 33628588
[TBL] [Abstract][Full Text] [Related]
19. Grape proanthocyanidins induce apoptosis by loss of mitochondrial membrane potential of human non-small cell lung cancer cells in vitro and in vivo.
Singh T; Sharma SD; Katiyar SK
PLoS One; 2011; 6(11):e27444. PubMed ID: 22087318
[TBL] [Abstract][Full Text] [Related]
20. MCM2 is a therapeutic target of lovastatin in human non-small cell lung carcinomas.
Zhang X; Teng Y; Yang F; Wang M; Hong X; Ye LG; Gao YN; Chen GY
Oncol Rep; 2015 May; 33(5):2599-605. PubMed ID: 25738322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
